Research location
Chennai
India
Advertisement
Research activity in Chennai
IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 224 trials and 283 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Chennai
224 linked trials · page 2 of 5Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)NCT02542293 · 2015-11-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in IndiaNCT02117622 · 2015-07-24 · 1 site observation
COMPLETED
Fostering Resilience to Psychosocial and HIV Risk in Indian MSMNCT02556294 · 2015-06-01 · 1 site observation
COMPLETED
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsNCT02322762 · 2014-12-30 · 1 site observation
COMPLETED
A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusNCT02302716 · 2014-12-01 · 1 site observation
COMPLETED
A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot UlcerNCT02236793 · 2014-12-01 · 3 site observations
COMPLETED
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsNCT02208921 · 2014-09-01 · 1 site observation
COMPLETED
Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast CancerNCT02162667 · 2014-06-01 · 2 site observations
COMPLETED
INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) StudyNCT02022111 · 2014-03-01 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint PacingNCT02006069 · 2013-12-01 · 1 site observation
TERMINATED
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR MutationNCT01953913 · 2013-09-30 · 1 site observation
COMPLETED
Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.NCT01779856 · 2013-01-01 · 1 site observation
COMPLETED
Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid ArthritisNCT01759030 · 2012-12-01 · 1 site observation
COMPLETED
Improving Cervical Cancer Screening Among HIV-Infected Women in IndiaNCT02247999 · 2012-11-28 · 1 site observation
COMPLETED
Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.NCT02472964 · 2012-07-01 · 1 site observation
COMPLETED
Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) StudyNCT01823887 · 2012-07-01 · 1 site observation
COMPLETED
Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement SurgeryNCT01635166 · 2012-07-01 · 1 site observation
TERMINATED
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based ChemotherapyNCT01523587 · 2012-03-05 · 3 site observations
COMPLETED
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimNCT01516736 · 2012-03-01 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerNCT01491737 · 2012-02-17 · 1 site observation
COMPLETED
Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 DiabetesNCT01512979 · 2012-01-01 · 1 site observation
COMPLETED
RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNCT01490086 · 2011-12-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed TherapyNCT01419197 · 2011-09-01 · 1 site observation
COMPLETED
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)NCT01431287 · 2011-09-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01361555 · 2011-08-01 · 1 site observation
TERMINATED
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01369095 · 2011-07-01 · 1 site observation
COMPLETED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
Phase IIb-III Study of BL-1020 Small Molecule for SchizophreniaNCT01363349 · 2011-05-01 · 1 site observation
TERMINATED
Long-Term Safety and Efficacy Study of Peginterferon Beta-1aNCT01332019 · 2011-04-01 · 1 site observation
COMPLETED
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease ProgressionNCT01230710 · 2011-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesNCT01289990 · 2011-02-01 · 2 site observations
COMPLETED
The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.NCT01295021 · 2011-02-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 2 site observations
COMPLETED
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly PeopleNCT01259297 · 2011-01-01 · 1 site observation
TERMINATED
A Rheumatoid Arthritis Study in ParticipantsNCT01202760 · 2011-01-01 · 1 site observation
COMPLETED
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 YearsNCT00799864 · 2011-01-01 · 1 site observation
COMPLETED
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenNCT01254279 · 2010-12-01 · 1 site observation
COMPLETED
A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateNCT01198002 · 2010-12-01 · 1 site observation
TERMINATED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 4 site observations
COMPLETED
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected FemalesNCT01031069 · 2010-10-26 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With MetforminNCT01210001 · 2010-09-01 · 2 site observations
COMPLETED
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderNCT01193153 · 2010-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesNCT01167881 · 2010-08-01 · 2 site observations
COMPLETED
Substituting Brown Rice For White Rice: Effect On Diabetes Risk Factors In IndiaNCT01814735 · 2010-08-01 · 1 site observation
COMPLETED
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma INCT01172808 · 2010-08-01 · 1 site observation
COMPLETED
ACT-293987 in Pulmonary Arterial HypertensionNCT01112306 · 2010-07-07 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesNCT01177813 · 2010-07-01 · 2 site observations
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.